BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 9746971)

  • 41. A comparative study of antipsychotic medication taking in people with schizophrenia.
    McCann TV; Deans C; Clark E; Lu S
    Int J Ment Health Nurs; 2008 Dec; 17(6):428-38. PubMed ID: 19128290
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Expert opinion on APAP (prolonged action atypical antipsychotic agents). Current status of recommendations for treatment with an APAP].
    Buis C; Gourion D; Vaiva G
    Encephale; 2009 Jan; Suppl 3():S91-5. PubMed ID: 19268185
    [No Abstract]   [Full Text] [Related]  

  • 43. [Compliance in the treatment of schizophrenia--project ADHES (the renewed results)].
    Chadzyńska M; Meder J; Tyszkowska M
    Psychiatr Pol; 2008; 42(4):561-70. PubMed ID: 19189600
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Treatment adherence as a social ability: a case of patients with schizophrenia].
    Baudrant-Boga M; Holtzmann J; Allenet B; Debeauchamp I; Giraud-Baro E
    J Pharm Belg; 2009 Sep; (3):91-8. PubMed ID: 19873850
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Partial compliance in schizophrenia and the impact on patient outcomes.
    Llorca PM
    Psychiatry Res; 2008 Nov; 161(2):235-47. PubMed ID: 18849080
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Medication compliance in patients with chronic schizophrenia: implications for the community management of mentally disordered offenders.
    Duncan JC; Rogers R
    J Forensic Sci; 1998 Nov; 43(6):1133-7. PubMed ID: 9846389
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Systemic family therapy in schizophrenia: a randomized clinical trial of effectiveness.
    Bressi C; Manenti S; Frongia P; Porcellana M; Invernizzi G
    Psychother Psychosom; 2008; 77(1):43-9. PubMed ID: 18087207
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Review of the evidence for the long-term efficacy of atypical antipsychotic agents in the treatment of patients with schizophrenia and related psychoses.
    Turner MS; Stewart DW
    J Psychopharmacol; 2006 Nov; 20(6 Suppl):20-37. PubMed ID: 17046985
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Comparison of patient and clinician perspectives in the assessment of antipsychotic medication adherence.
    Barbui C; Kikkert M; Mazzi MA; Becker T; Bindman J; Schene A; Nosè M; Helm H; Thornicroft G; Tansella M
    Psychopathology; 2009; 42(5):311-7. PubMed ID: 19672133
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Longterm therapy of schizophrenia].
    Pajonk FG; Wobrock T; Falkai P
    Fortschr Neurol Psychiatr; 2005 Mar; 73(3):161-74; quiz 175-7. PubMed ID: 15747226
    [No Abstract]   [Full Text] [Related]  

  • 51. Violence among schizophrenia out-patients compliant with medication: prevalence and associated factors.
    Bobes J; Fillat O; Arango C
    Acta Psychiatr Scand; 2009 Mar; 119(3):218-25. PubMed ID: 19178395
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Compliance in psychiatry].
    Cesková E
    Cas Lek Cesk; 2009; 148(10):489-92. PubMed ID: 20662411
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Psychological effects of previous treatment experiences with neuroleptics].
    Bossert S; Dose M; Emrich HM; Garcia D; Junker M; Raptis K; Weber MM
    Nervenarzt; 1990 May; 61(5):301-5. PubMed ID: 1972785
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Clinical study of drug compliance in long-term treatment for schizophrenia].
    Waseda T
    Seishin Shinkeigaku Zasshi; 1998; 100(5):261-90. PubMed ID: 9695687
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Negative vs. positive therapy expectations and compliance vs. noncompliance].
    Linden M
    Psychiatr Prax; 1987 Jul; 14(4):132-6. PubMed ID: 2887002
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Insight and adherence to treatment in psychotic disorders.
    Kemp RA; David AS
    Br J Hosp Med; 1995 Sep 6-19; 54(5):222-7. PubMed ID: 8528530
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Effects of interventions to improve compliance with antipsychotic medication in people suffering from schizophrenia-results of recent reviews].
    Puschner B; Born A; Giessler A; Helm H; Becker T; Angermeyer MC
    Psychiatr Prax; 2005 Mar; 32(2):62-7. PubMed ID: 15712037
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Medication adherence studies in schizophrenia.
    Hamann J; Pitschel-Walz G; Kissling W
    Am J Psychiatry; 2004 Mar; 161(3):582; author reply 582-3. PubMed ID: 14992997
    [No Abstract]   [Full Text] [Related]  

  • 59. [Education groups in neuroleptic treatment of schizophrenic patients].
    Gaillard P; Degiovanni A; Parrot F
    Ann Med Psychol (Paris); 1993 Apr; 151(4):340-2. PubMed ID: 7904433
    [No Abstract]   [Full Text] [Related]  

  • 60. Virtual reality assessment of medication compliance in patients with schizophrenia.
    Baker EK; Kurtz MM; Astur RS
    Cyberpsychol Behav; 2006 Apr; 9(2):224-9. PubMed ID: 16640484
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.